Virologica Sinica

, Volume 31, Issue 5, pp 380–394 | Cite as

Structure-function relationship of the mammarenavirus envelope glycoprotein

  • Wei Wang
  • Zheng Zhou
  • Leike Zhang
  • Shaobo Wang
  • Gengfu Xiao
Review

Abstract

Mammarenaviruses, including lethal pathogens such as Lassa virus and Junín virus, can cause severe hemorrhagic fever in humans. Entry is a key step for virus infection, which starts with binding of the envelope glycoprotein (GP) to receptors on target cells and subsequent fusion of the virus with target cell membranes. The GP precursor is synthesized as a polypeptide, and maturation occurs by two cleavage events, yielding a tripartite GP complex (GPC) formed by a stable signal peptide (SSP), GP1 and GP2. The unique retained SSP interacts with GP2 and plays essential roles in virion maturation and infectivity. GP1 is responsible for binding to the cell receptor, and GP2 is a class I fusion protein. The native structure of the tripartite GPC is unknown. GPC is critical for the receptor binding, membrane fusion and neutralization antibody recognition. Elucidating the molecular mechanisms underlining the structure–function relationship of the three subunits is the key for understanding their function and can facilitate novel avenues for combating virus infections. This review summarizes the basic aspects and recent research of the structure–function relationship of the three subunits. We discuss the structural basis of the receptor-binding domain in GP1, the interaction between SSP and GP2 and its role in virion maturation and membrane fusion, as well as the mechanism by which glycosylation stabilizes the GPC structure and facilitates immune evasion. Understanding the molecular mechanisms involved in these aspects will contribute to the development of novel vaccines and treatment strategies against mammarenaviruses infection.

Keywords

Mammarenaviruses glycoprotein complex (GPC) stable signal peptide (SSP) membrane fusion glycosylation 

References

  1. Abraham J, Corbett KD, Farzan M, Choe H, Harrison SC. 2010. Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses. Nat Struct Mol Biol, 17: 438–444.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Abraham J, Kwong JA, Albarino CG, Lu JG, Radoshitzky SR, Salazar-Bravo J, Farzan M, Spiropoulou CF, Choe H. 2009. Hostspecies transferrin receptor 1 orthologs are cellular receptors for nonpathogenic new world clade B arenaviruses. PLoS Pathog, 5: e1000358.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Agnihothram SS, York J, Nunberg JH. 2006. Role of the stable signal peptide and cytoplasmic domain of G2 in regulating intracellular transport of the Junin virus envelope glycoprotein complex. J Virol, 80: 5189–5198.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Agnihothram SS, York J, Trahey M, Nunberg JH. 2007. Bitopic membrane topology of the stable signal peptide in the tripartite Junin virus GP-C envelope glycoprotein complex. J Virol, 81: 4331–4337.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Albarino CG, Bird BH, Chakrabarti AK, Dodd KA, Flint M, Bergeron E, White DM, Nichol ST. 2011a. The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain. J Virol, 85: 10404–10408.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Albarino CG, Bird BH, Chakrabarti AK, Dodd KA, White DM, Bergeron E, Shrivastava-Ranjan P, Nichol ST. 2011b. Reverse genetics generation of chimeric infectious Junin/Lassa virus is dependent on interaction of homologous glycoprotein stable signal peptide and G2 cytoplasmic domains. J Virol, 85: 112–122.PubMedCrossRefGoogle Scholar
  7. Armstrong C, Lillie RD. 1934. Experimental lymphocytic choriomeningitis of monkeys and mice produced by a virus encountered in studies of the 1933 St Louis encephalitis epidemic. Public Health Rep., 49: 1019–1027.CrossRefGoogle Scholar
  8. Bederka LH, Bonhomme CJ, Ling EL, Buchmeier MJ. 2014. Arenavirus stable signal peptide is the keystone subunit for glycoprotein complex organization. MBio, 5: e02063.PubMedPubMedCentralCrossRefGoogle Scholar
  9. Bedossa P, Ferlicot S, Paradis V, Dargere D, Bonvoust F, Vidaud M. 2002. Dystroglycan expression in hepatic stellate cells: role in liver fibrosis. Lab Invest, 82: 1053–1061.PubMedCrossRefGoogle Scholar
  10. Beyer WR, Popplau D, Garten W, von Laer D, Lenz O. 2003. Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P. J Virol, 77: 2866–2872.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Bolken TC, Laquerre S, Zhang Y, Bailey TR, Pevear DC, Kickner SS, Sperzel LE, Jones KF, Warren TK, Amanda Lund S, Kirkwood-Watts DL, King DS, Shurtleff AC, Guttieri MC, Deng Y, Bleam M, Hruby DE. 2006. Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses. Antiviral Res, 69: 86–97.PubMedCrossRefGoogle Scholar
  12. Bonhomme CJ, Capul AA, Lauron EJ, Bederka LH, Knopp KA, Buchmeier MJ. 2011. Glycosylation modulates arenavirus glycoprotein expression and function. Virology, 409: 223–233.PubMedCrossRefGoogle Scholar
  13. Bonhomme CJ, Knopp KA, Bederka LH, Angelini MM, Buchmeier MJ. 2013. LCMV glycosylation modulates viral fitness and cell tropism. PLoS One, 8: e53273.PubMedPubMedCentralCrossRefGoogle Scholar
  14. Borrow P, Oldstone MB. 1994. Mechanism of lymphocytic choriomeningitis virus entry into cells. Virology, 198: 1–9.PubMedCrossRefGoogle Scholar
  15. Bowden TA, Crispin M, Graham SC, Harvey DJ, Grimes JM, Jones EY, Stuart DI. 2009. Unusual molecular architecture of the machupo virus attachment glycoprotein. J Virol, 83: 8259–8265.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Bowen MD, Peters CJ, Nichol ST. 1996. The phylogeny of New World (Tacaribe complex) arenaviruses. Virology, 219: 285–290.PubMedCrossRefGoogle Scholar
  17. Bowen MD, Peters CJ, Nichol ST. 1997. Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol Phylogenet Evol, 8: 301–316.PubMedCrossRefGoogle Scholar
  18. Braakman I, van Anken E. 2000. Folding of viral envelope glycoproteins in the endoplasmic reticulum. Traffic, 1: 533–539.PubMedCrossRefGoogle Scholar
  19. Branco LM, Grove JN, Moses LM, Goba A, Fullah M, Momoh M, Schoepp RJ, Bausch DG, Garry RF. 2010. Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects. Virol J, 7: 306.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Briknarova K, Thomas CJ, York J, Nunberg JH. 2011. Structure of a zinc-binding domain in the Junin virus envelope glycoprotein. J Biol Chem, 286: 1528–1536.PubMedCrossRefGoogle Scholar
  21. Buchmeier MJ, de la Torre JC, Peters CJ. 2007. Fields Virology, 4th edn. Philadelphia: Lippincott-Raven, pp. 1791–1828.Google Scholar
  22. Burns JW, Buchmeier MJ. 1991. Protein-protein interactions in lymphocytic choriomeningitis virus. Virology, 183: 620–629.PubMedCrossRefGoogle Scholar
  23. Burri DJ, da Palma JR, Seidah NG, Zanotti G, Cendron L, Pasquato A, Kunz S. 2013. Differential recognition of Old World and New World arenavirus envelope glycoproteins by subtilisin kexin isozyme 1 (SKI-1)/site 1 protease (S1P). J Virol, 87: 6406–6414.PubMedPubMedCentralCrossRefGoogle Scholar
  24. Burri DJ, Pasqual G, Rochat C, Seidah NG, Pasquato A, Kunz S. 2012. Molecular characterization of the processing of arenavirus envelope glycoprotein precursors by subtilisin kexin isozyme-1/site-1 protease. J Virol, 86: 4935–4946.PubMedPubMedCentralCrossRefGoogle Scholar
  25. Cajimat MN, Milazzo ML, Rollin PE, Nichol ST, Bowen MD, Ksiazek TG, Fulhorst CF. 2009. Genetic diversity among Bolivian arenaviruses. Virus Res, 140: 24–31.PubMedCrossRefGoogle Scholar
  26. Cao W, Henry MD, Borrow P, Yamada H, Elder JH, Ravkov EV, Nichol ST, Compans RW, Campbell KP, Oldstone MB. 1998. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science, 282: 2079–2081.PubMedCrossRefGoogle Scholar
  27. Cashman KA, Smith MA, Twenhafel NA, Larson RA, Jones KF, Allen RD, 3rd, Dai D, Chinsangaram J, Bolken TC, Hruby DE, Amberg SM, Hensley LE, Guttieri MC. 2011. Evaluation of Lassa antiviral compound ST-193 in a guinea pig model. Antiviral Res, 90: 70–79.PubMedPubMedCentralCrossRefGoogle Scholar
  28. Charrel RN, Feldmann H, Fulhorst CF, Khelifa R, de Chesse R, de Lamballerie X. 2002. Phylogeny of New World arenaviruses based on the complete coding sequences of the small genomic segment identified an evolutionary lineage produced by intrasegmental recombination. Biochem Biophys Res Commun, 296: 1118–1124.PubMedCrossRefGoogle Scholar
  29. Clegg JC. 2002. Molecular phylogeny of the arenaviruses. Curr Top Microbiol Immunol, 262: 1–24.PubMedGoogle Scholar
  30. Cohen-Dvashi H, Cohen N, Israeli H, Diskin R. 2015. Molecular Mechanism for LAMP1 Recognition by Lassa Virus. J Virol, 89: 7584–7592.PubMedPubMedCentralCrossRefGoogle Scholar
  31. Cosset FL, Marianneau P, Verney G, Gallais F, Tordo N, Pecheur EI, ter Meulen J, Deubel V, Bartosch B. 2009. Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles. J Virol, 83: 3228–3237.PubMedPubMedCentralCrossRefGoogle Scholar
  32. da Palma JR, Burri DJ, Oppliger J, Salamina M, Cendron L, de Laureto PP, Seidah NG, Kunz S, Pasquato A. 2014. Zymogen activation and subcellular activity of subtilisin kexin isozyme 1/site 1 protease. J Biol Chem, 289: 35743–35756.PubMedPubMedCentralCrossRefGoogle Scholar
  33. Di Simone C, Zandonatti MA, Buchmeier MJ. 1994. Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike. Virology, 198: 455–465.PubMedCrossRefGoogle Scholar
  34. Droniou-Bonzom ME, Reignier T, Oldenburg JE, Cox AU, Exline CM, Rathbun JY, Cannon PM. 2011. Substitutions in the glycoprotein (GP) of the Candid#1 vaccine strain of Junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of GP. J Virol, 85: 13457–13462.PubMedPubMedCentralCrossRefGoogle Scholar
  35. Eichler R, Lenz O, Garten W, Strecker T. 2006. The role of single N-glycans in proteolytic processing and cell surface transport of the Lassa virus glycoprotein GP-C. Virol J, 3: 41.PubMedPubMedCentralCrossRefGoogle Scholar
  36. Eichler R, Lenz O, Strecker T, Eickmann M, Klenk HD, Garten W. 2003a. Identification of Lassa virus glycoprotein signal peptide as a trans-acting maturation factor. EMBO Rep, 4: 1084–1088.PubMedPubMedCentralCrossRefGoogle Scholar
  37. Eichler R, Lenz O, Strecker T, Eickmann M, Klenk HD, Garten W. 2004a. Lassa virus glycoprotein signal peptide displays a novel topology with an extended endoplasmic reticulum luminal region. J Biol Chem, 279: 12293–12299.PubMedCrossRefGoogle Scholar
  38. Eichler R, Lenz O, Strecker T, Garten W. 2003b. Signal peptide of Lassa virus glycoprotein GP-C exhibits an unusual length. FEBS Lett, 538: 203–206.PubMedCrossRefGoogle Scholar
  39. Eichler R, Strecker T, Kolesnikova L, ter Meulen J, Weissenhorn W, Becker S, Klenk HD, Garten W, Lenz O. 2004b. Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res, 100: 249–255.PubMedCrossRefGoogle Scholar
  40. Emonet S, Lemasson JJ, Gonzalez JP, de Lamballerie X, Charrel RN. 2006. Phylogeny and evolution of old world arenaviruses. Virology, 350: 251–257.PubMedCrossRefGoogle Scholar
  41. Enria DA, Barrera Oro JG. 2002. Junin virus vaccines. Curr Top Microbiol Immunol, 263: 239–261.PubMedGoogle Scholar
  42. Eschli B, Quirin K, Wepf A, Weber J, Zinkernagel R, Hengartner H. 2006. Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I viral fusion proteins. J Virol, 80: 5897–5907.PubMedPubMedCentralCrossRefGoogle Scholar
  43. Eschli B, Zellweger RM, Wepf A, Lang KS, Quirin K, Weber J, Zinkernagel RM, Hengartner H. 2007. Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus. J Virol, 81: 11650–11657.PubMedPubMedCentralCrossRefGoogle Scholar
  44. Fisher-Hoch SP, McCormick JB. 2001. Towards a human Lassa fever vaccine. Rev Med Virol, 11: 331–341.PubMedCrossRefGoogle Scholar
  45. Flanagan ML, Oldenburg J, Reignier T, Holt N, Hamilton GA, Martin VK, Cannon PM. 2008. New world clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and -independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1. J Virol, 82: 938–948.PubMedCrossRefGoogle Scholar
  46. Froeschke M, Basler M, Groettrup M, Dobberstein B. 2003. Long-lived signal peptide of lymphocytic choriomeningitis virus glycoprotein pGP-C. J Biol Chem, 278: 41914–41920.PubMedCrossRefGoogle Scholar
  47. Fuller-Pace FV, Southern PJ. 1989. Detection of virus-specific RNA-dependent RNA polymerase activity in extracts from cells infected with lymphocytic choriomeningitis virus: in vitro synthesis of full-length viral RNA species. J Virol, 63: 1938–1944.PubMedPubMedCentralGoogle Scholar
  48. Garces F, Lee JH, de Val N, Torrents de la Pena A, Kong L, Puchades C, Hua Y, Stanfield RL, Burton DR, Moore JP, Sanders RW, Ward AB, Wilson IA. 2015. Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans. Immunity, 43: 1053–1063.PubMedCrossRefGoogle Scholar
  49. Garces F, Sok D, Kong L, McBride R, Kim HJ, Saye-Francisco KF, Julien JP, Hua Y, Cupo A, Moore JP, Paulson JC, Ward AB, Burton DR, Wilson IA. 2014. Structural evolution of glycan recognition by a family of potent HIV antibodies. Cell, 159: 69–79.PubMedPubMedCentralCrossRefGoogle Scholar
  50. Garcin D, Kolakofsky D. 1990. A novel mechanism for the initiation of Tacaribe arenavirus genome replication. J Virol, 64: 6196–6203.PubMedPubMedCentralGoogle Scholar
  51. Goncalves AR, Moraz ML, Pasquato A, Helenius A, Lozach PY, Kunz S. 2013. Role of DC-SIGN in Lassa virus entry into human dendritic cells. J Virol, 87: 11504–11515.PubMedPubMedCentralCrossRefGoogle Scholar
  52. Gunther S, Emmerich P, Laue T, Kuhle O, Asper M, Jung A, Grewing T, ter Meulen J, Schmitz H. 2000. Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. Emerg Infect Dis, 6: 466–476.PubMedPubMedCentralCrossRefGoogle Scholar
  53. Hara Y, Kanagawa M, Kunz S, Yoshida-Moriguchi T, Satz JS, Kobayashi YM, Zhu Z, Burden SJ, Oldstone MB, Campbell KP. 2011. Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection. Proc Natl Acad Sci U S A, 108: 17426–17431.PubMedPubMedCentralCrossRefGoogle Scholar
  54. Harrison SC. 2008. Viral membrane fusion. Nat Struct Mol Biol, 15: 690–698.PubMedPubMedCentralCrossRefGoogle Scholar
  55. Hastie KM, Igonet S, Sullivan BM, Legrand P, Zandonatti MA, Robinson JE, Garry RF, Rey FA, Oldstone MB, Saphire EO. 2016. Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV. Nat Struct Mol Biol, 23: 513–521.PubMedPubMedCentralCrossRefGoogle Scholar
  56. Igonet S, Vaney MC, Vonrhein C, Bricogne G, Stura EA, Hengartner H, Eschli B, Rey FA. 2011. X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation. Proc Natl Acad Sci U S A, 108: 19967–19972.PubMedPubMedCentralCrossRefGoogle Scholar
  57. Imperiali M, Thoma C, Pavoni E, Brancaccio A, Callewaert N, Oxenius A. 2005. O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function. J Virol, 79: 14297–14308.PubMedPubMedCentralCrossRefGoogle Scholar
  58. Jae LT, Raaben M, Herbert AS, Kuehne AI, Wirchnianski AS, Soh TK, Stubbs SH, Janssen H, Damme M, Saftig P, Whelan SP, Dye JM, Brummelkamp TR. 2014. Lassa virus entry requires a trigger-induced receptor switch. Science, 344: 1506–1510.PubMedPubMedCentralCrossRefGoogle Scholar
  59. Jae LT, Raaben M, Riemersma M, van Beusekom E, Blomen VA, Velds A, Kerkhoven RM, Carette JE, Topaloglu H, Meinecke P, Wessels MW, Lefeber DJ, Whelan SP, van Bokhoven H, Brummelkamp TR. 2013. Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry. Science, 340: 479–483.PubMedPubMedCentralCrossRefGoogle Scholar
  60. Johnson KM, McCormick JB, Webb PA, Smith ES, Elliott LH, King IJ. 1987. Clinical virology of Lassa fever in hospitalized patients. J Infect Dis, 155: 456–464.PubMedCrossRefGoogle Scholar
  61. Klewitz C, Klenk HD, ter Meulen J. 2007. Amino acids from both N-terminal hydrophobic regions of the Lassa virus envelope glycoprotein GP-2 are critical for pH-dependent membrane fusion and infectivity. J Gen Virol, 88: 2320–2328.PubMedCrossRefGoogle Scholar
  62. Kong L, Lee JH, Doores KJ, Murin CD, Julien JP, McBride R, Liu Y, Marozsan A, Cupo A, Klasse PJ, Hoffenberg S, Caulfield M, King CR, Hua Y, Le KM, Khayat R, Deller MC, Clayton T, Tien H, Feizi T, Sanders RW, Paulson JC, Moore JP, Stanfield RL, Burton DR, Ward AB, Wilson IA. 2013. Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat Struct Mol Biol, 20: 796–803.PubMedPubMedCentralCrossRefGoogle Scholar
  63. Kranzusch PJ, Whelan SP. 2012. Architecture and regulation of negative-strand viral enzymatic machinery. RNA Biol, 9: 941–948.PubMedPubMedCentralCrossRefGoogle Scholar
  64. Kunz S, Edelmann KH, de la Torre JC, Gorney R, Oldstone MB. 2003. Mechanisms for lymphocytic choriomeningitis virus glycoprotein cleavage, transport, and incorporation into virions. Virology, 314: 168–178.PubMedCrossRefGoogle Scholar
  65. Kunz S, Rojek JM, Kanagawa M, Spiropoulou CF, Barresi R, Campbell KP, Oldstone MB. 2005. Posttranslational modification of alpha-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding. J Virol, 79: 14282–14296.PubMedPubMedCentralCrossRefGoogle Scholar
  66. Landau M, Mayrose I, Rosenberg Y, Glaser F, Martz E, Pupko T, Ben-Tal N. 2005. ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Res, 33: W299–W302.PubMedPubMedCentralCrossRefGoogle Scholar
  67. Larson RA, Dai D, Hosack VT, Tan Y, Bolken TC, Hruby DE, Amberg SM. 2008. Identification of a broad-spectrum arenavirus entry inhibitor. J Virol, 82: 10768–10775.PubMedPubMedCentralCrossRefGoogle Scholar
  68. Lee AM, Rojek JM, Spiropoulou CF, Gundersen AT, Jin W, Shaginian A, York J, Nunberg JH, Boger DL, Oldstone MB, Kunz S. 2008. Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses. J Biol Chem, 283: 18734–18742.PubMedPubMedCentralCrossRefGoogle Scholar
  69. Lenz O, ter Meulen J, Klenk HD, Seidah NG, Garten W. 2001. The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc Natl Acad Sci U S A, 98: 12701–12705.PubMedPubMedCentralCrossRefGoogle Scholar
  70. Leung WC, Leung MF, Rawls WE. 1979. Distinctive RNA transcriptase, polyadenylic acid polymerase, and polyuridylic acid polymerase activities associated with Pichinde virus. J Virol, 30: 98–107.PubMedPubMedCentralGoogle Scholar
  71. Li S, Sun Z, Pryce R, Parsy ML, Fehling SK, Schlie K, Siebert CA, Garten W, Bowden TA, Strecker T, Huiskonen JT. 2016. Acidic pH-Induced Conformations and LAMP1 Binding of the Lassa Virus Glycoprotein Spike. PLoS Pathog, 12: e1005418.PubMedPubMedCentralCrossRefGoogle Scholar
  72. Maiztegui JI, McKee KT, Jr., Barrera Oro JG, Harrison LH, Gibbs PH, Feuillade MR, Enria DA, Briggiler AM, Levis SC, Ambrosio AM, Halsey NA, Peters CJ. 1998. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group. J Infect Dis, 177: 277–283.CrossRefGoogle Scholar
  73. Martinez MG, Bialecki MA, Belouzard S, Cordo SM, Candurra NA, Whittaker GR. 2013. Utilization of human DC-SIGN and LSIGN for entry and infection of host cells by the New World arenavirus, Junin virus. Biochem Biophys Res Commun, 441: 612–617.PubMedPubMedCentralCrossRefGoogle Scholar
  74. Martinez MG, Cordo SM, Candurra NA. 2007. Characterization of Junin arenavirus cell entry. J Gen Virol, 88: 1776–1784.PubMedCrossRefGoogle Scholar
  75. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, Elliott LH, Belmont-Williams R. 1986. Lassa fever. Effective therapy with ribavirin. N Engl J Med, 314: 20–26.PubMedGoogle Scholar
  76. Messina EL, York J, Nunberg JH. 2012. Dissection of the role of the stable signal peptide of the arenavirus envelope glycoprotein in membrane fusion. J Virol, 86: 6138–6145.PubMedPubMedCentralCrossRefGoogle Scholar
  77. Meulen J, Badusche M, Satoguina J, Strecker T, Lenz O, Loeliger C, Sakho M, Koulemou K, Koivogui L, Hoerauf A. 2004. Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones. Virology, 321: 134–143.PubMedCrossRefGoogle Scholar
  78. Meyer BJ, de la Torre JC, Southern PJ. 2002. Arenaviruses: genomic RNAs, transcription, and replication. Curr Top Microbiol Immunol, 262: 139–157.PubMedGoogle Scholar
  79. Mouquet H, Scharf L, Euler Z, Liu Y, Eden C, Scheid JF, Halper-Stromberg A, Gnanapragasam PN, Spencer DI, Seaman MS, Schuitemaker H, Feizi T, Nussenzweig MC, Bjorkman PJ. 2012. Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proc Natl Acad Sci U S A, 109: E3268–3277.PubMedPubMedCentralCrossRefGoogle Scholar
  80. Ngo N, Cubitt B, Iwasaki M, de la Torre JC. 2015. Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication. J Virol, 89: 10924–10933.PubMedPubMedCentralCrossRefGoogle Scholar
  81. Oldstone MB. 2007. A suspenseful game of 'hide and seek' between virus and host. Nat Immunol, 8: 325–327.PubMedCrossRefGoogle Scholar
  82. Parsy ML, Harlos K, Huiskonen JT, Bowden TA. 2013. Crystal structure of Venezuelan hemorrhagic fever virus fusion glycoprotein reveals a class 1 postfusion architecture with extensive glycosylation. J Virol, 87: 13070–13075.PubMedPubMedCentralCrossRefGoogle Scholar
  83. Pasqual G, Rojek JM, Masin M, Chatton JY, Kunz S. 2011. Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport. PLoS Pathog, 7: e1002232.PubMedPubMedCentralCrossRefGoogle Scholar
  84. Pasquato A, Burri DJ, Traba EG, Hanna- El-Daher L, Seidah NG, Kunz S. 2011. Arenavirus envelope glycoproteins mimic autoprocessing sites of the cellular proprotein convertase subtilisin kexin isozyme-1/site-1 protease. Virology, 417: 18–26.PubMedCrossRefGoogle Scholar
  85. Pejchal R, Doores KJ, Walker LM, Khayat R, Huang PS, Wang SK, Stanfield RL, Julien JP, Ramos A, Crispin M, Depetris R, Katpally U, Marozsan A, Cupo A, Maloveste S, Liu Y, McBride R, Ito Y, Sanders RW, Ogohara C, Paulson JC, Feizi T, Scanlan CN, Wong CH, Moore JP, Olson WC, Ward AB, Poignard P, Schief WR, Burton DR, Wilson IA. 2011. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science, 334: 1097–1103.PubMedPubMedCentralCrossRefGoogle Scholar
  86. Perez M, Craven RC, de la Torre JC. 2003. The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A, 100: 12978–12983.PubMedPubMedCentralCrossRefGoogle Scholar
  87. Pinschewer DD, Perez M, de la Torre JC. 2003. Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication. J Virol, 77: 3882–3887.PubMedPubMedCentralCrossRefGoogle Scholar
  88. Pushko P, Geisbert J, Parker M, Jahrling P, Smith J. 2001. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses. J Virol, 75: 11677–11685.PubMedPubMedCentralCrossRefGoogle Scholar
  89. Quirin K, Eschli B, Scheu I, Poort L, Kartenbeck J, Helenius A. 2008. Lymphocytic choriomeningitis virus uses a novel endocytic pathway for infectious entry via late endosomes. Virology, 378: 21–33.PubMedCrossRefGoogle Scholar
  90. Radoshitzky SR, Abraham J, Spiropoulou CF, Kuhn JH, Nguyen D, Li W, Nagel J, Schmidt PJ, Nunberg JH, Andrews NC, Farzan M, Choe H. 2007. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature, 446: 92–96.PubMedPubMedCentralCrossRefGoogle Scholar
  91. Radoshitzky SR, Bao Y, Buchmeier MJ, Charrel RN, Clawson AN, Clegg CS, De Risi JL, Emonet S, Gonzalez JP, Kuhn JH, Lukashevich IS, Peters CJ, Romanowski V, Salvato MS, Stenglein MD, de la Torre JC. 2015. Past, present, and future of arenavirus taxonomy. Arch Virol, 160: 1851–1874.PubMedCrossRefGoogle Scholar
  92. Radoshitzky SR, Longobardi LE, Kuhn JH, Retterer C, Dong L, Clester JC, Kota K, Carra J, Bavari S. 2011. Machupo virus glycoprotein determinants for human transferrin receptor 1 binding and cell entry. PLoS One, 6: e21398.PubMedPubMedCentralCrossRefGoogle Scholar
  93. Robert X, Gouet P. 2014. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res, 42: W320–W324.PubMedPubMedCentralCrossRefGoogle Scholar
  94. Robinson JE, Hastie KM, Cross RW, Yenni RE, Elliott DH, Rouelle JA, Kannadka CB, Smira AA, Garry CE, Bradley BT, Yu H, Shaffer JG, Boisen ML, Hartnett JN, Zandonatti MA, Rowland MM, Heinrich ML, Martinez-Sobrido L, Cheng B, de la Torre JC, Andersen KG, Goba A, Momoh M, Fullah M, Gbakie M, Kanneh L, Koroma VJ, Fonnie R, Jalloh SC, Kargbo B, Vandi MA, Gbetuwa M, Ikponmwosa O, Asogun DA, Okokhere PO, Follarin OA, Schieffelin JS, Pitts KR, Geisbert JB, Kulakoski PC, Wilson RB, Happi CT, Sabeti PC, Gevao SM, Khan SH, Grant DS, Geisbert TW, Saphire EO, Branco LM, Garry RF. 2016. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits. Nat Commun, 7: 11544.PubMedPubMedCentralCrossRefGoogle Scholar
  95. Rojek JM, Campbell KP, Oldstone MB, Kunz S. 2007a. Old World arenavirus infection interferes with the expression of functional alpha-dystroglycan in the host cell. Mol Biol Cell, 18: 4493–4507.PubMedPubMedCentralCrossRefGoogle Scholar
  96. Rojek JM, Kunz S. 2008. Cell entry by human pathogenic arenaviruses. Cell Microbiol, 10: 828–835.PubMedCrossRefGoogle Scholar
  97. Rojek JM, Lee AM, Nguyen N, Spiropoulou CF, Kunz S. 2008a. Site 1 protease is required for proteolytic processing of the glycoproteins of the South American hemorrhagic fever viruses Junin, Machupo, and Guanarito. J Virol, 82: 6045–6051.PubMedPubMedCentralCrossRefGoogle Scholar
  98. Rojek JM, Sanchez AB, Nguyen NT, de la Torre JC, Kunz S. 2008b. Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J Virol, 82: 7677–7687.PubMedPubMedCentralCrossRefGoogle Scholar
  99. Rojek JM, Spiropoulou CF, Campbell KP, Kunz S. 2007b. Old World and clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by alpha-dystroglycan's host-derived ligands. J Virol, 81: 5685–5695.PubMedPubMedCentralCrossRefGoogle Scholar
  100. Salvato MS, Clegg JCS, Buchmeier MJ, Charrel RN, Gonzalez JP, Lukashevich IS, Peters CJ, Rico-Hesse R, Romanowski V. 2005. Family Arenaviridae. In: Virus Taxonomy, Eighth report of the International Committee on Taxonomy of Viruses. Van Regenmortel MHV, Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA (Eds.). Cambridge: Academic Press.Google Scholar
  101. Salvato MS, Schweighofer KJ, Burns J, Shimomaye EM. 1992. Biochemical and immunological evidence that the 11 kDa zinc-binding protein of lymphocytic choriomeningitis virus is a structural component of the virus. Virus Res, 22: 185–198.PubMedCrossRefGoogle Scholar
  102. Salvato MS, Shimomaye EM. 1989. The completed sequence of lymphocytic choriomeningitis virus reveals a unique RNA structure and a gene for a zinc finger protein. Virology, 173: 1–10.PubMedCrossRefGoogle Scholar
  103. Saunders AA, Ting JP, Meisner J, Neuman BW, Perez M, de la Torre JC, Buchmeier MJ. 2007. Mapping the landscape of the lymphocytic choriomeningitis virus stable signal peptide reveals novel functional domains. J Virol, 81: 5649–5657.PubMedPubMedCentralCrossRefGoogle Scholar
  104. Schmitt AP, Leser GP, Morita E, Sundquist WI, Lamb RA. 2005. Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J Virol, 79: 2988–2997.PubMedPubMedCentralCrossRefGoogle Scholar
  105. Schrempf S, Froeschke M, Giroglou T, von Laer D, Dobberstein B. 2007. Signal peptide requirements for lymphocytic choriomeningitis virus glycoprotein C maturation and virus infectivity. J Virol, 81: 12515–12524.PubMedPubMedCentralCrossRefGoogle Scholar
  106. Schwarz F, Aebi M. 2011. Mechanisms and principles of N-linked protein glycosylation. Curr Opin Struct Biol, 21: 576–582.PubMedCrossRefGoogle Scholar
  107. Seregin AV, Yun NE, Miller M, Aronson J, Smith JK, Walker AG, Smith JN, Huang C, Manning JT, de la Torre JC, Paessler S. 2015. The glycoprotein precursor gene of Junin virus determines the virulence of the Romero strain and the attenuation of the Candid #1 strain in a representative animal model of Argentine hemorrhagic fever. J Virol, 89: 5949–5956.PubMedPubMedCentralCrossRefGoogle Scholar
  108. Shimojima M, Kawaoka Y. 2012. Cell Surface Molecules Involved in Infection Mediated by Lymphocytic Choriomeningitis Virus Glycoprotein. J Vet Med Sci, 74: 1363–1366.PubMedCrossRefGoogle Scholar
  109. Shimojima M, Stroher U, Ebihara H, Feldmann H, Kawaoka Y. 2012. Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry. J Virol, 86: 2067–2078.PubMedPubMedCentralCrossRefGoogle Scholar
  110. Sommerstein R, Flatz L, Remy MM, Malinge P, Magistrelli G, Fischer N, Sahin M, Bergthaler A, Igonet S, Ter Meulen J, Rigo D, Meda P, Rabah N, Coutard B, Bowden TA, Lambert PH, Siegrist CA, Pinschewer DD. 2015. Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection. PLoS Pathog, 11: e1005276.PubMedPubMedCentralCrossRefGoogle Scholar
  111. Spence JS, Melnik LI, Badani H, Wimley WC, Garry RF. 2014. Inhibition of arenavirus infection by a glycoprotein-derived peptide with a novel mechanism. J Virol, 88: 8556–8564.PubMedPubMedCentralCrossRefGoogle Scholar
  112. Strecker T, Eichler R, Meulen J, Weissenhorn W, Dieter Klenk H, Garten W, Lenz O. 2003. Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J Virol, 77: 10700–10705.PubMedPubMedCentralCrossRefGoogle Scholar
  113. Tani H, Iha K, Shimojima M, Fukushi S, Taniguchi S, Yoshikawa T, Kawaoka Y, Nakasone N, Ninomiya H, Saijo M, Morikawa S. 2014. Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus. J Virol, 88: 7317–7330.PubMedPubMedCentralCrossRefGoogle Scholar
  114. ter Meulen J, Badusche M, Kuhnt K, Doetze A, Satoguina J, Marti T, Loeliger C, Koulemou K, Koivogui L, Schmitz H, Fleischer B, Hoerauf A. 2000. Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein. J Virol, 74: 2186–2192.PubMedPubMedCentralCrossRefGoogle Scholar
  115. Vela EM, Zhang L, Colpitts TM, Davey RA, Aronson JF. 2007. Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism. Virology, 369: 1–11.PubMedPubMedCentralCrossRefGoogle Scholar
  116. Walker LM, Huber M, Doores KJ, Falkowska E, Pejchal R, Julien JP, Wang SK, Ramos A, Chan-Hui PY, Moyle M, Mitcham JL, Hammond PW, Olsen OA, Phung P, Fling S, Wong CH, Phogat S, Wrin T, Simek MD, Protocol GPI, Koff WC, Wilson IA, Burton DR, Poignard P. 2011. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature, 477: 466–470.PubMedPubMedCentralCrossRefGoogle Scholar
  117. Weber EL, Buchmeier MJ. 1988. Fine mapping of a peptide sequence containing an antigenic site conserved among arenaviruses. Virology, 164: 30–38.PubMedCrossRefGoogle Scholar
  118. Wright KE, Salvato MS, Buchmeier MJ. 1989. Neutralizing epitopes of lymphocytic choriomeningitis virus are conformational and require both glycosylation and disulfide bonds for expression. Virology, 171: 417–426.PubMedCrossRefGoogle Scholar
  119. Yamamoto T, Kato Y, Karita M, Kawaguchi M, Shibata N, Kobayashi M. 2004. Expression of genes related to muscular dystrophy with lissencephaly. Pediatr Neurol, 31: 183–190.PubMedCrossRefGoogle Scholar
  120. York J, Agnihothram SS, Romanowski V, Nunberg JH. 2005. Genetic analysis of heptad-repeat regions in the G2 fusion subunit of the Junin arenavirus envelope glycoprotein. Virology, 343: 267–274.PubMedCrossRefGoogle Scholar
  121. York J, Dai D, Amberg SM, Nunberg JH. 2008. pH-induced activation of arenavirus membrane fusion is antagonized by small-molecule inhibitors. J Virol, 82: 10932–10939.PubMedPubMedCentralCrossRefGoogle Scholar
  122. York J, Nunberg JH. 2006. Role of the stable signal peptide of Junin arenavirus envelope glycoprotein in pH-dependent membrane fusion. J Virol, 80: 7775–7780.PubMedPubMedCentralCrossRefGoogle Scholar
  123. York J, Nunberg JH. 2007a. Distinct requirements for signal peptidase processing and function in the stable signal peptide subunit of the Junin virus envelope glycoprotein. Virology, 359: 72–81.PubMedCrossRefGoogle Scholar
  124. York J, Nunberg JH. 2007b. A novel zinc-binding domain is essential for formation of the functional Junin virus envelope glycoprotein complex. J Virol, 81: 13385–13391.PubMedPubMedCentralCrossRefGoogle Scholar
  125. York J, Nunberg JH. 2009. Intersubunit interactions modulate pHinduced activation of membrane fusion by the Junin virus envelope glycoprotein GPC. J Virol, 83: 4121–4126.PubMedPubMedCentralCrossRefGoogle Scholar
  126. York J, Romanowski V, Lu M, Nunberg JH. 2004. The signal peptide of the Junin arenavirus envelope glycoprotein is myristoylated and forms an essential subunit of the mature G1-G2 complex. J Virol, 78: 10783–10792.PubMedPubMedCentralCrossRefGoogle Scholar
  127. Young PR, Howard CR. 1983. Fine structure analysis of Pichinde virus nucleocapsids. J Gen Virol, 64: 833–842.PubMedCrossRefGoogle Scholar

Copyright information

© Wuhan Institute of Virology, CAS and Springer Science+Business Media Singapore 2016

Authors and Affiliations

  • Wei Wang
    • 1
  • Zheng Zhou
    • 1
  • Leike Zhang
    • 1
  • Shaobo Wang
    • 1
  • Gengfu Xiao
    • 1
  1. 1.State Key Laboratory of Virology, Wuhan Institute of VirologyChinese Academy of SciencesWuhanChina

Personalised recommendations